ANI Pharmaceuticals announced that it has acquired the NDA for Lithobid from Noven Therapeutics. Total consideration for the product was $12M including an $11M upfront payment and a $1M future ...
PITTSBURGH (AP) -- Mylan has begun selling generic versions of the allergy drug Clarinex and also the bipolar disorder treatment Lithobid. The products starting shipping after approval was granted by ...
BAUDETTE, Minn., July 1, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ANIP -.00% today announced that it has acquired the NDA for Lithobid® (lithium carbonate extended release 300 mg tablets) from ...
Mylan announced the launch of Lithium Carbonate Extended-release Tablets 300mg, the generic version of Noven Therapeutic‘s Lithobid Tablets. Lithobid is indicated for the treatment of manic episodes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results